<?xml version="1.0" encoding="UTF-8"?>
<ref id="B154">
 <mixed-citation publication-type="book">
  <person-group person-group-type="author">
   <collab>EMA</collab>
  </person-group> (
  <year>2015</year>b). “
  <article-title>Public statement on prioritisation forassessment of herbal substances associated with safety concerns</article-title>,” in 
  <source>EMA/HMPC/682247/2013 Rev. 1 Committee on Herbal Medicinal Products (HMPC)</source> (
  <publisher-loc>London</publisher-loc>: 
  <publisher-name>European Medicines Agency</publisher-name>). 
 </mixed-citation>
</ref>
